This inventor holds 1 USPTO granted patent. Top assignee: Schrodinger, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Aleksey Gerasyuto: Innovator in Cancer Treatment
Introduction
Aleksey Gerasyuto is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective therapies that target specific cancer pathways.
Latest Patents
Aleksey holds a patent for "Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of cancer." This patent describes compounds of Formula (I) and their pharmaceutically acceptable salts. The application outlines pharmaceutical compositions that include these compounds and methods for using them to inhibit kinase activity, ultimately aiming to treat cancer effectively.
Career Highlights
Aleksey is currently employed at Schrodinger, LLC, where he continues to advance his research in the pharmaceutical industry. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.
Collaborations
Aleksey collaborates with Xianhai Huang, contributing to the advancement of their shared goals in cancer research and drug development.
Conclusion
Aleksey Gerasyuto's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the pharmaceutical field. His ongoing work promises to impact the future of cancer therapies significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile